Your browser doesn't support javascript.
loading
Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.
Varma, Vijay R; Desai, Rishi J; Navakkode, Sheeja; Wong, Lik-Wei; Anerillas, Carlos; Loeffler, Tina; Schilcher, Irene; Mahesri, Mufaddal; Chin, Kristyn; Horton, Daniel B; Kim, Seoyoung C; Gerhard, Tobias; Segal, Jodi B; Schneeweiss, Sebastian; Gorospe, Myriam; Sajikumar, Sreedharan; Thambisetty, Madhav.
Afiliación
  • Varma VR; Clinical and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA.
  • Desai RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Navakkode S; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Wong LW; Department of Physiology, National University of Singapore, Singapore, Singapore.
  • Anerillas C; Department of Physiology, National University of Singapore, Singapore, Singapore.
  • Loeffler T; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Schilcher I; Laboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, USA.
  • Mahesri M; QPS Austria GmbH, Parkring 12, 8074, Grambach, Austria.
  • Chin K; QPS Austria GmbH, Parkring 12, 8074, Grambach, Austria.
  • Horton DB; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kim SC; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Gerhard T; Center for Pharmacoepidemiology and Treatment Science, Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, USA.
  • Segal JB; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Schneeweiss S; Center for Pharmacoepidemiology and Treatment Science, Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, USA.
  • Gorospe M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Sajikumar S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Thambisetty M; Laboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, USA.
Mol Psychiatry ; 28(3): 1312-1326, 2023 03.
Article en En | MEDLINE | ID: mdl-36577843
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos